Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.
Subcutaneous Enoxaparin Safely Facilitates Bedside Sustained Low-Efficiency Hemodialysis in Hypercoagulopathic Coronavirus Disease 2019 Patients - A Proof-of-Principle Trial
This study describes a simple and safe protocol of anticoagulation with low molecular weight heparin (LMWH) in combination with bedside sustained low efficiency hemodialysis (SLED) in COVID-19 patients.
Authors: Neumann-Haefelin E, Widmeier E, Bansbach J, et al. Crit Care Explor 2020.
Estimated Time: 09:16 min
Categories:
Crisis Management, Hematology, Pharmacology,
Content Type:
Articles,